Apply treatment strategies for cytomegalovirus (CMV) infection in transplant recipients. Identify refractory or drug-resistant CMV in transplant recipients in the post-transplant setting. Integrate new antiviral therapies into management regimens for transplant recipients, including those who develop refractory or drug-resistant CMV.
- Provider:RMEI Medical Education, LLC
- Activity Link: https://rmei.com
- Start Date: 2024-12-02 06:00:00
- End Date: 2024-12-02 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - Commercial Support: Source: Takeda Pharmaceuticals (Any division) - Amount: 68780.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest